| Control | 33% Crown | 33% Dominant | 33% Low | 50% Crown | 50% Dominant | 50% Low |
---|---|---|---|---|---|---|---|
1Â year post-treatment | |||||||
N | 4822 ± 2169 (1963–7258) | 1761 ± 617 (988–2654) | 2481 ± 1123 (1407–4333) | 1473 ± 478 (1074–2185) | 1446 ± 550 (926–2432) | 1979 ± 1185 (1049–3975) | 874 ± 187 (654–1197) |
DBH | 10.2 ± 5.0 (0.8–47.8) | 12.0 ± 5.3 (1.0–30.5) | 10.3 ± 4.0 (1.3–23.1) | 14.6 ± 4.6 (1.3–35.1) | 11.7 ± 5.8 (1.3–32.3) | 10.1 ± 3.8 (1.3–29.7) | 16.9 ± 4.7 (2.5–31.2) |
ΔBA | 1.98 ± 3.75 (0–40.28) | 3.43 ± 5.40 (0–52.44) | 2.65 ± 3.87 (0–44.39) | 4.94 ± 5.74 (0–49.57) | 5.00 ± 7.17 (0–54.12) | 2.93 ± 4.86 (0–50.72) | 6.93 ± 6.91 (0–44.39) |
10Â years post-treatment | |||||||
N | 3259 ± 1076 (1703–4320) | 1107 ± 428 (506–1605) | 1378 ± 824 (568–2679) | 1323 ± 436 (951–2049) | 796 ± 462 (432–1691) | 866 ± 781 (173–2210) | 710 ± 212 (506–1062) |
DBH | 13.0 ± 5.5 (1.5–52.6) | 15.4 ± 6.4 (2.0–36.3) | 13.5 ± 5.0 (1.5–29.7) | 17.3 ± 5.2 (2.3–43.9) | 16.2 ± 7.4 (1.3–36.1) | 13.3 ± 4.9 (2.5–32.0) | 20.3 ± 5.0 (4.8–36.6) |
ΔBA | 2.87 ± 5.30 (0–73.37) | 6.89 ± 8.85 (0–65.11) | 6.17 ± 8.00 (0–72.97) | 7.29 ± 8.50 (0–64.61) | 8.73 ± 12.17 (0–88.17) | 7.65 ± 9.98 (0–78.44) | 10.29 ± 10.04 (0–61.57) |